KR100947194B1 - 종양 세포에서 선택적으로 증식하는 종양 융해 바이러스 - Google Patents
종양 세포에서 선택적으로 증식하는 종양 융해 바이러스 Download PDFInfo
- Publication number
- KR100947194B1 KR100947194B1 KR1020097005916A KR20097005916A KR100947194B1 KR 100947194 B1 KR100947194 B1 KR 100947194B1 KR 1020097005916 A KR1020097005916 A KR 1020097005916A KR 20097005916 A KR20097005916 A KR 20097005916A KR 100947194 B1 KR100947194 B1 KR 100947194B1
- Authority
- KR
- South Korea
- Prior art keywords
- gene
- cells
- virus
- tumor
- human
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
- A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Virology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (3)
- hTERT 프로모터, E1A 유전자, IRES 배열 및 E1B 유전자를 이 순서로 포함하는, 아데노바이러스에 삽입하기 위한 콘스트럭트로서,hTERT 프로모터의 염기 배열이 배열 번호 4 로 나타내는 염기 배열로 이루어지고, E1A 유전자의 염기 배열이 배열 번호 1 로 나타내는 염기 배열로 이루어지며, IRES 배열의 염기 배열이 배열 번호 3 으로 나타내는 염기 배열로 이루어지고, 또한 E1B 유전자의 염기 배열이 배열 번호 2 로 나타내는 염기 배열로 이루어지는 상기 콘스트럭트.
- 제 1 항에 기재된 콘스트럭트를 포함하는 아데노바이러스.
- 유효성분으로서 제 2 항에 기재된 아데노바이러스 및 약학적으로 허용되는 담체, 부형제 또는 희석제를 함유하는 항암제.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JPJP-P-2002-198941 | 2002-07-08 | ||
JP2002198941A JP3867968B2 (ja) | 2002-07-08 | 2002-07-08 | 腫瘍細胞において選択的に増殖する腫瘍融解ウイルス |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020057000306A Division KR20050075867A (ko) | 2002-07-08 | 2003-07-07 | 종양 세포에서 선택적으로 증식하는 종양 융해 바이러스 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20090043589A KR20090043589A (ko) | 2009-05-06 |
KR100947194B1 true KR100947194B1 (ko) | 2010-03-11 |
Family
ID=30112441
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020097005916A KR100947194B1 (ko) | 2002-07-08 | 2003-07-07 | 종양 세포에서 선택적으로 증식하는 종양 융해 바이러스 |
KR1020057000306A KR20050075867A (ko) | 2002-07-08 | 2003-07-07 | 종양 세포에서 선택적으로 증식하는 종양 융해 바이러스 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020057000306A KR20050075867A (ko) | 2002-07-08 | 2003-07-07 | 종양 세포에서 선택적으로 증식하는 종양 융해 바이러스 |
Country Status (15)
Country | Link |
---|---|
US (1) | US20060239967A1 (ko) |
EP (1) | EP1553178B1 (ko) |
JP (1) | JP3867968B2 (ko) |
KR (2) | KR100947194B1 (ko) |
CN (1) | CN100430476C (ko) |
AU (1) | AU2003281310B2 (ko) |
CA (1) | CA2491907C (ko) |
DK (1) | DK1553178T3 (ko) |
ES (1) | ES2455127T3 (ko) |
HK (1) | HK1082958A1 (ko) |
NZ (1) | NZ537631A (ko) |
PL (1) | PL374644A1 (ko) |
PT (1) | PT1553178E (ko) |
WO (1) | WO2004005511A1 (ko) |
ZA (1) | ZA200500047B (ko) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7473418B2 (en) | 2004-03-25 | 2009-01-06 | Cell Genesys, Inc. | Pan cancer oncolytic vectors and methods of use thereof |
EP1745801A1 (en) * | 2004-05-13 | 2007-01-24 | Daiichi Pharmaceutical Co., Ltd. | Method of inhibiting telomerase activity and inhibitor |
CN100361710C (zh) * | 2004-06-07 | 2008-01-16 | 成都康弘生物科技有限公司 | 肿瘤细胞专一表达免疫调节因子gm-csf的溶瘤性腺病毒重组体的构建及其应用 |
US7943373B2 (en) * | 2004-09-29 | 2011-05-17 | Oncolys Biopharma, Inc. | Telomelysin/GFP-expressing recombinant virus |
WO2006085689A1 (ja) * | 2005-02-10 | 2006-08-17 | Oncolys Biopharma, Inc. | テロメライシン併用抗癌剤 |
JP5069871B2 (ja) * | 2006-05-30 | 2012-11-07 | シスメックス株式会社 | 新規な癌細胞検出試料調製用キット及びそれを用いた癌細胞検出用キット |
WO2008065726A1 (fr) * | 2006-11-29 | 2008-06-05 | Oncolys Biopharma Inc. | Agent contenant du télomelysin destiné à rompre la tolérance anti-tumorale |
WO2008136213A1 (ja) * | 2007-04-27 | 2008-11-13 | Oncolys Biopharma Inc. | 放射線増感増強剤 |
US20090181931A1 (en) * | 2008-01-16 | 2009-07-16 | Oncolys Biopharma, Inc. | Antiviral activity of cidofovir against oncolytic viruses |
CN102257156A (zh) | 2008-12-18 | 2011-11-23 | 希森美康株式会社 | 血样中癌细胞的检测方法 |
JP6323978B2 (ja) | 2010-12-24 | 2018-05-16 | アークレイ株式会社 | 癌細胞の検出方法 |
CN106591368A (zh) * | 2016-10-12 | 2017-04-26 | 郑州大学 | 携带il‑15r/il‑15融合基因的b亚群腺病毒11载体及其构建和用途 |
US11617765B2 (en) | 2017-10-10 | 2023-04-04 | Yamaguchi University | Enhancer for T-cells or B-cells having memory function, malignant tumor recurrence inhibitor, and inducer for inducing memory function in T-cells or B-cells |
JPWO2020230838A1 (ko) * | 2019-05-14 | 2020-11-19 | ||
BR112022007952A2 (pt) | 2019-10-28 | 2022-10-04 | Noile Immune Biotech Inc | Medicamento para tratar câncer, medicamento de combinação, composição de medicamento, célula imunorresponsiva, veículo de entrega de ácido nucleico e produto |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999020108A1 (en) * | 1997-10-23 | 1999-04-29 | Uab Research Foundation | Human papillomavirus vectors for the episomal transduction of host cells and method of making same |
CA2362367C (en) * | 1999-02-04 | 2004-08-03 | Geron Corporation | Telomerase reverse transcriptase transcriptional regulatory sequences |
US6692736B2 (en) * | 2000-03-24 | 2004-02-17 | Cell Genesys, Inc. | Cell-specific adenovirus vectors comprising an internal ribosome entry site |
ATE412058T1 (de) | 2000-03-24 | 2008-11-15 | Cell Genesys Inc | Interne ribosomenzugangsstelle-enthaltende zell- spezifische adenovirale vektoren |
IL152420A0 (en) * | 2001-02-23 | 2003-05-29 | Novartis Ag | Novel oncolytic adenoviral vectors |
CN1177042C (zh) * | 2001-04-12 | 2004-11-24 | 上海华康生物技术有限公司 | 共表达人p53基因和人细胞因子基因的重组腺病毒及其制法和用途 |
CN1195056C (zh) * | 2001-07-12 | 2005-03-30 | 钱其军 | 一种在肿瘤细胞中特异性增殖及高效表达抗癌基因的重组病毒及其构建方法 |
-
2002
- 2002-07-08 JP JP2002198941A patent/JP3867968B2/ja not_active Expired - Lifetime
-
2003
- 2003-07-07 KR KR1020097005916A patent/KR100947194B1/ko active IP Right Grant
- 2003-07-07 AU AU2003281310A patent/AU2003281310B2/en not_active Expired
- 2003-07-07 WO PCT/JP2003/008573 patent/WO2004005511A1/ja active Application Filing
- 2003-07-07 US US10/520,901 patent/US20060239967A1/en not_active Abandoned
- 2003-07-07 CN CNB038160641A patent/CN100430476C/zh not_active Expired - Lifetime
- 2003-07-07 CA CA2491907A patent/CA2491907C/en not_active Expired - Lifetime
- 2003-07-07 EP EP03741222.8A patent/EP1553178B1/en not_active Expired - Lifetime
- 2003-07-07 KR KR1020057000306A patent/KR20050075867A/ko not_active Application Discontinuation
- 2003-07-07 ES ES03741222.8T patent/ES2455127T3/es not_active Expired - Lifetime
- 2003-07-07 DK DK03741222.8T patent/DK1553178T3/da active
- 2003-07-07 NZ NZ537631A patent/NZ537631A/en not_active IP Right Cessation
- 2003-07-07 PT PT37412228T patent/PT1553178E/pt unknown
- 2003-07-07 PL PL03374644A patent/PL374644A1/xx not_active Application Discontinuation
-
2005
- 2005-01-04 ZA ZA200500047A patent/ZA200500047B/en unknown
-
2006
- 2006-03-03 HK HK06102821.5A patent/HK1082958A1/xx not_active IP Right Cessation
Non-Patent Citations (2)
Title |
---|
Cancer Res. Vol.62(13):3743-3750 (2002.07.01) |
Hum. Gene Ther., Vol.13(9):1015-1025 (2002.06.10) |
Also Published As
Publication number | Publication date |
---|---|
CA2491907A1 (en) | 2004-01-15 |
DK1553178T3 (da) | 2014-05-19 |
PL374644A1 (en) | 2005-10-31 |
JP2004033186A (ja) | 2004-02-05 |
AU2003281310A1 (en) | 2004-01-23 |
KR20050075867A (ko) | 2005-07-22 |
WO2004005511A1 (ja) | 2004-01-15 |
JP3867968B2 (ja) | 2007-01-17 |
ES2455127T3 (es) | 2014-04-14 |
US20060239967A1 (en) | 2006-10-26 |
ZA200500047B (en) | 2006-05-31 |
HK1082958A1 (en) | 2006-06-23 |
KR20090043589A (ko) | 2009-05-06 |
CN1665927A (zh) | 2005-09-07 |
EP1553178B1 (en) | 2014-03-05 |
PT1553178E (pt) | 2014-06-12 |
CN100430476C (zh) | 2008-11-05 |
AU2003281310B2 (en) | 2008-02-21 |
CA2491907C (en) | 2013-03-19 |
EP1553178A1 (en) | 2005-07-13 |
NZ537631A (en) | 2007-05-31 |
EP1553178A4 (en) | 2006-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100947194B1 (ko) | 종양 세포에서 선택적으로 증식하는 종양 융해 바이러스 | |
US20240100106A1 (en) | Isolated recombinant oncolytic adenoviruses, pharmaceutical compositions, and uses thereof for drugs for treatment of tumors and/or cancers | |
Toyoda et al. | Oncolytic treatment and cure of neuroblastoma by a novel attenuated poliovirus in a novel poliovirus-susceptible animal model | |
US10280420B2 (en) | Cancer specific-splicing ribozyme and use thereof | |
ES2212815T3 (es) | Virus citopaticos para la terapia y profilaxis de neoplasia. | |
KR20120049185A (ko) | 암 치료용 암 용해성 아데노바이러스 | |
EP2682459B1 (en) | Oncolytic adenovirus for target therapy of human tumor and use thereof | |
AU2017299983A1 (en) | Recombinant vaccinia virus and use thereof | |
KR102252423B1 (ko) | 암 특이적 트랜스-스플라이싱 리보자임 및 이의 용도 | |
JP4361708B2 (ja) | 複製−コンピテント抗癌ベクター | |
JP2015506697A (ja) | 12量体trail及びhsv−tk自殺遺伝子を同時に発現するベクター並びにそれを用いた抗癌幹細胞治療剤 | |
CN111607610A (zh) | 癌症特异性反式剪接核酶及其用途 | |
WO2003006640A1 (fr) | Virus a proliferation specifique dans les cellules tumorales, qui peut exprimer un antioncogene avec une grande efficacite, et utilisation de ce virus | |
WO2019020543A1 (en) | ONCOLYTIC VIRUSES EXPRESSING AGENTS TARGETING METABOLIC IMMUNE MODULATORS | |
CN116670172A (zh) | 表达免疫检查点抑制剂的癌症特异性反式剪接核酶及其用途 | |
US20040171159A1 (en) | Cell-specific adenovirus vector comprising EBV-specific promoter | |
KR102471898B1 (ko) | 면역관문 억제제를 발현하는 암 특이적 트랜스-스플라이싱 리보자임 및 이의 용도 | |
US8163892B2 (en) | Oncolytic virus replicating selectively in tumor cells | |
CN114703186B (zh) | 肿瘤特异性启动子及其应用 | |
JP5580043B2 (ja) | 放射線増感増強剤 | |
AU2022210147A1 (en) | Cancer-specific trans-splicing ribozyme expressing immune checkpoint inhibitor, and use thereor | |
CN117417962A (zh) | 一种多靶点溶瘤腺病毒的构建方法及应用 | |
JP5494916B2 (ja) | 腫瘍特異的プロモーターおよびその用途 | |
TW200533752A (en) | Pan cancer oncolytic vectors and methods of use thereof | |
WO2015118056A1 (en) | Conditionally replicating adenovirus and use thereof in the treatment of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
N231 | Notification of change of applicant | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130305 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20140219 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20150223 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20160302 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20170224 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20180223 Year of fee payment: 9 |